Pharmaceuticals #novo nordisk#eli lilly
Ozempic-maker Novo Nordisk sues Eli Lilly for false advertising over weight-loss drug claims
Novo Nordisk has sued Eli Lilly, alleging false advertising in Eli Lilly's campaigns that compare weight-loss and diabetes drugs. Novo claims Eli Lilly intentionally used outdated studies and omitted higher-dose options to create a misleading impression of superiority. The lawsuit seeks to pull the ads and run corrective advertising.
Jul 21, 2026 1 source